IBDEI0W2 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15035,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery w/ Unstable Angina
 ;;^UTILITY(U,$J,358.3,15035,1,4,0)
 ;;=4^I25.110
 ;;^UTILITY(U,$J,358.3,15035,2)
 ;;=^5007108
 ;;^UTILITY(U,$J,358.3,15036,0)
 ;;=I25.119^^56^636^4
 ;;^UTILITY(U,$J,358.3,15036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15036,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery w/ Unspec Angina
 ;;^UTILITY(U,$J,358.3,15036,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,15036,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,15037,0)
 ;;=I48.0^^56^636^20
 ;;^UTILITY(U,$J,358.3,15037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15037,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,15037,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,15037,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,15038,0)
 ;;=I48.1^^56^636^21
 ;;^UTILITY(U,$J,358.3,15038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15038,1,3,0)
 ;;=3^Persistent Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,15038,1,4,0)
 ;;=4^I48.1
 ;;^UTILITY(U,$J,358.3,15038,2)
 ;;=^5007225
 ;;^UTILITY(U,$J,358.3,15039,0)
 ;;=I48.2^^56^636^9
 ;;^UTILITY(U,$J,358.3,15039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15039,1,3,0)
 ;;=3^Chronic Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,15039,1,4,0)
 ;;=4^I48.2
 ;;^UTILITY(U,$J,358.3,15039,2)
 ;;=^5007226
 ;;^UTILITY(U,$J,358.3,15040,0)
 ;;=I48.92^^56^636^6
 ;;^UTILITY(U,$J,358.3,15040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15040,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,15040,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,15040,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,15041,0)
 ;;=I48.3^^56^636^24
 ;;^UTILITY(U,$J,358.3,15041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15041,1,3,0)
 ;;=3^Typical Atrial Flutter
 ;;^UTILITY(U,$J,358.3,15041,1,4,0)
 ;;=4^I48.3
 ;;^UTILITY(U,$J,358.3,15041,2)
 ;;=^5007227
 ;;^UTILITY(U,$J,358.3,15042,0)
 ;;=I48.4^^56^636^7
 ;;^UTILITY(U,$J,358.3,15042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15042,1,3,0)
 ;;=3^Atypical Atrial Flutter
 ;;^UTILITY(U,$J,358.3,15042,1,4,0)
 ;;=4^I48.4
 ;;^UTILITY(U,$J,358.3,15042,2)
 ;;=^5007228
 ;;^UTILITY(U,$J,358.3,15043,0)
 ;;=Z71.89^^56^637^1
 ;;^UTILITY(U,$J,358.3,15043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15043,1,3,0)
 ;;=3^Counseling,Other Specified
 ;;^UTILITY(U,$J,358.3,15043,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,15043,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,15044,0)
 ;;=Z71.7^^56^637^2
 ;;^UTILITY(U,$J,358.3,15044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15044,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,15044,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,15044,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,15045,0)
 ;;=Z76.89^^56^637^4
 ;;^UTILITY(U,$J,358.3,15045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15045,1,3,0)
 ;;=3^Persons Encountering Health Services for Oth Circumstances
 ;;^UTILITY(U,$J,358.3,15045,1,4,0)
 ;;=4^Z76.89
 ;;^UTILITY(U,$J,358.3,15045,2)
 ;;=^5063304
 ;;^UTILITY(U,$J,358.3,15046,0)
 ;;=Z01.812^^56^637^3
 ;;^UTILITY(U,$J,358.3,15046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15046,1,3,0)
 ;;=3^Lab Result Counseling
 ;;^UTILITY(U,$J,358.3,15046,1,4,0)
 ;;=4^Z01.812
 ;;^UTILITY(U,$J,358.3,15046,2)
 ;;=^5062627
 ;;^UTILITY(U,$J,358.3,15047,0)
 ;;=E03.9^^56^638^25
 ;;^UTILITY(U,$J,358.3,15047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15047,1,3,0)
 ;;=3^Hypothroidism,Unspec
 ;;^UTILITY(U,$J,358.3,15047,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,15047,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,15048,0)
 ;;=E11.9^^56^638^22
 ;;^UTILITY(U,$J,358.3,15048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15048,1,3,0)
 ;;=3^DM Type 2 w/o Complications
